<DOC>
	<DOCNO>NCT01933321</DOCNO>
	<brief_summary>Autologous cell therapy patient ALS stimulate neuroplasticity , modify neurodegenerative process stop clinical progression disease .</brief_summary>
	<brief_title>Effect Intrathecal Administration Hematopoietic Stem Cells Patients With Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description>There extensive information</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>patient confirm diagnosis ALS accord El Escorial criterion . Diagnosistime le four year . Over 18 year old . Forced vital capacity â‰¥ 40 % . One year evolution . Adequate nutritional state Severe bulbar ALS involucre . Inadequate nutritional status . Spondylotic myelopathy , abnormality image study . Having concomitant neurological psychiatric disease . Systemic disease poorcontrol . History treatment steroid immunoglobulin last year . Participate past three month Clinical Trial . History malignancy cancer today . Intracranial hypertension . Clinical suggestive data infection site lumbar puncture . Tracheostomy . Use mechanical ventilation . Forced vital capacity le 40 % . HIVseropositive presence antibody hepatitis B C serological study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>ALS , stem cell</keyword>
</DOC>